{"cluster": 31, "subcluster": 18, "abstract_summ": "Methods A retrospective analysis of consecutive patients admitted to Temple University Hospital in Philadelphia, Pennsylvania, from March 10, 2020, to May 17, 2020 with moderate to severe respiratory failure treated with High Flow nasal therapy (HFNT).We would like to encourage the use of CPAP, better tolerated for extended hours with lower oxygen flows, in patients with COVID-19 pneumonia, where acute respiratory distress all too often leads to patient intubation and the genesis of deleterious lung lesions.It was recently described that COVID-19 pneumonia patients had an atypical form of the ARDS syndrome and required gentle ventilation.From 27th March to 23rd April, consecutive patients receiving 10 to 15 l/min of oxygen with a non-rebreather mask, who had signs of respiratory failure or were unable to maintain an SpO2 > 90%, were treated by CPAP with a face-mask unless the ICU physician judged that immediate intubation was indicated.INTERPRETATION: The population of patients suspected for COVID-19 infection presenting at our ED showed a very high rate of severe respiratory failure, with urgent need of a large amount of intensive care resources.", "title_summ": "Case ReportSeverity of respiratory failure and outcome of patients needing a ventilatory support in the Emergency Department during Italian novel coronavirus SARS-CoV2 outbreak: Preliminary data on the role of Helmet CPAP and Non-Invasive Positive Pressure VentilationROX Index Predicts Intubation in Patients with COVID-19 Pneumonia and Moderate to Severe Hypoxemic Respiratory Failure Receiving High Flow Nasal Therapy.Continuous positive airway pressure face-mask ventilation to manage massive influx of patients requiring respiratory support during the SARS-CoV-2 outbreakUse of High Flow Nasal Therapy to Treat Moderate to Severe Hypoxemic Respiratory Failure in COVID-19Is continuous positive airway pressure (CPAP) a new standard of care for type 1 respiratory failure in COVID-19 patients?A retrospective observational study of a dedicated COVID-19 CPAP serviceCPAP Added to Oxygen Administration Avoid Intubation in Acute Respiratory Distress in COVID-19 Pneumonia.Audit results from Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust.", "title_abstract_phrases": "We would like to encourage the use of CPAP, better tolerated for extended hours with lower oxygen flows, in patients with COVID-19 pneumonia, where acute respiratory distress all too often leads to patient intubation and the genesis of deleterious lung lesions.Methods A retrospective analysis of consecutive patients admitted to Temple University Hospital in Philadelphia, Pennsylvania, from March 10, 2020, to May 17, 2020 with moderate to severe respiratory failure treated with High Flow nasal therapy (HFNT).Case ReportIt was recently described that COVID-19 pneumonia patients had an atypical form of the ARDS syndrome and required gentle ventilation.From 27th March to 23rd April, consecutive patients receiving 10 to 15 l/min of oxygen with a non-rebreather mask, who had signs of respiratory failure or were unable to maintain an SpO2 > 90%, were treated by CPAP with a face-mask unless the ICU physician judged that immediate intubation was indicated.INTERPRETATION: The population of patients suspected for COVID-19 infection presenting at our ED showed a very high rate of severe respiratory failure, with urgent need of a large amount of intensive care resources."}